Saturday 17 October 2026
Export LUCD’s income statement to Excel — free account
Lucid Diagnostics Inc.
LUCD Healthcare Medical Devices
Lucid Diagnostics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, up 8.28% from fiscal 2024. In the quarter to June 2026, revenue grew 26.7%, EPS was flat, free cash flow fell 7.04% and total debt fell 7.11%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
0.48
0.04
−7.69%
Follow LUCD
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
— | — | — | — | — | — | 4 | 5 | 4 |
P/S ratio |
— | — | — | — | 0.00 | 74.27 | 23.90 | 9.53 | 23.61 |
Altman Z-Score |
— | — | — | — | 12.63 | (6.21) | (12.64) | (13.05) | (10.91) |
P/FCF ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | 13.95 | (15.69) | (31.81) | (31.13) | (28.53) |
P/Operating CF |
— | — | — | — | (10.11) | (11.81) | (5.82) | (4.20) | (8.83) |
P/B ratio |
— | — | — | — | 1.83 | 2.18 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | — | — | — | 1.83 | 2.57 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | — | — | 0.00 | 42.49 | 21.87 | 8.67 | 21.34 |
EV/EBITDA |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | (3.89) | (0.97) | (1.62) | (0.85) | (2.16) |
EV/FCF |
— | — | — | — | (3.70) | (0.94) | (1.61) | (0.85) | (2.15) |
Quick Ratio |
— | 0.02 | 0.02 | 0.01 | 12.64 | 2.67 | 0.64 | 0.95 | 1.24 |
Current Ratio |
— | 0.02 | 0.06 | 0.09 | 13.45 | 2.89 | 0.75 | 1.07 | 1.31 |
Net Debt/EBITDA |
— | 0.02 | 0.04 | 0.01 | 1.96 | 0.40 | 0.11 | 0.08 | 0.22 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.96% | 51.16% | 60.56% | 59.34% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | (6.04) | 3.45 | 2.19 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.08 | 0.15 | 0.13 |
Operating CF/Net income |
— | 0.10 | 0.53 | 0.68 | 0.63 | 0.53 | 0.62 | 0.83 | 0.66 |
Capex/Depreciation |
— | — | — | — | (215.50) | (0.47) | (0.09) | (0.55) | (0.23) |
Interest Coverage |
— | — | — | — | (41.61) | (7,031.37) | (116.54) | (1,771.23) | (2,256.36) |
| — | 35.34% | 138.75% | 87.96% | (136.23%) | (144.42%) | (4,989.67%) | 151.58% | 152.80% | |
| — | (12,650.56%) | (840.64%) | (512.87%) | (91.77%) | (122.77%) | (176.20%) | (182.89%) | (198.34%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (1,582.35%) | (2,290.35%) | 0.00% | (1,762.55%) | (13,430.74%) |
Return on Tangible Assets |
— | 105.95% | 74.27% | 58.01% | (51.98%) | (320.56%) | 881.44% | (1,974.13%) | (727.89%) |
Average Days of Receivables |
— | — | — | — | 146.00 | 16.46 | 6.76 | 3.78 | 49.87 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 1,859.20% | 2,985.94% | 298.68% | 137.87% | 120.65% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 3,607.60% | 10,638.73% | 1,468.62% | 842.59% | 883.49% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.05 | 0.02 | 0.01 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | 1,919.80% | 3,976.39% | 280.97% | 104.33% | 95.43% |
Graham Net Nets |
— | — | — | — | 0.53 | 0.30 | (0.13) | 0.00 | 0.07 |
Graham Number |
— | — | — | — | 0.00 | 0.00 | 3.79 | 4.86 | 3.03 |
Earnings Yield |
— | — | — | — | (28.03%) | (111.55%) | (91.37%) | (131.71%) | (88.07%) |
Free Cash Flow Yield |
— | — | — | — | (18.55%) | (60.85%) | (56.92%) | (107.27%) | (42.01%) |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.03 | 0.01 | 0.06 | 0.09 | 0.05 |
Operating CF per Share |
— | 0.00 | (0.06) | (0.40) | (0.95) | (0.82) | (0.79) | (0.87) | (0.46) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | (0.05) | (0.03) | (0.01) | (0.01) | 0.00 |
Free Cash Flow per Share |
— | 0.00 | (0.06) | (0.40) | (1.00) | (0.85) | (0.79) | (0.89) | (0.46) |
Cash per Share |
— | 0.00 | 0.00 | 0.01 | 2.88 | 0.62 | 0.45 | 0.44 | 0.34 |
Shareholders Equity per Share |
— | (0.03) | (0.14) | (0.96) | 2.94 | 0.64 | (0.06) | 0.11 | 0.11 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (0.03) | (0.14) | (0.96) | 2.94 | 0.64 | (0.06) | 0.11 | 0.11 |
Free Cash Flow |
— | (0.11) | (2.36) | (5.63) | (18.53) | (30.59) | (33.04) | (44.79) | (46.68) |
Working Capital |
— | (1.06) | (5.95) | (14.27) | 53.04 | 15.93 | (7.31) | 1.62 | 8.89 |
Capital Expenditures |
— | — | — | — | (0.86) | (0.91) | (0.22) | (0.65) | (0.20) |
Net Current Asset Value |
— | (1.06) | (5.95) | (14.27) | 53.04 | 14.89 | (7.51) | (0.18) | 7.96 |
EV/EBIT |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | — | 1.72 | 2.41 | 0.09 | 0.15 | 0.04 |
Price to Operating Income |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | — | — | — | 0.00 | 1.22 | 1.87 | 1.10 | 1.08 |
Cash ROIC |
— | 10.88% | 45.83% | 41.99% | (17.09%) | (65.82%) | (108.20%) | (96.63%) | (67.03%) |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | 3.47 | 78.32 | 96.58 | 13.68 |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.33 | 2.84 | 5.43 | 5.95 | 6.03 |
Inventory Turnover |
— | — | — | — | 0.00 | 0.00 | 30.74 | 22.94 | 19.22 |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 929.66 | 106.65 | 69.96 | 63.81 | 53.08 |
Days of Inventory on Hand |
— | — | — | — | 0.00 | 11.21 | 16.97 | 17.53 | 19.32 |
Average Receivables |
— | — | — | — | — | 0.11 | 0.03 | 0.05 | 0.34 |
Average Payables |
— | 0.65 | 0.65 | 1.43 | 1.77 | 1.27 | 1.10 | 1.19 | 1.11 |
Average Inventory |
— | — | — | — | — | — | 0.19 | 0.31 | 0.35 |
Average Assets |
— | 0.01 | 0.53 | 1.61 | 30.60 | 45.75 | 29.89 | 28.99 | 35.58 |
Average Common Equity |
— | (3.19) | (3.19) | (9.41) | 20.61 | 38.89 | 1.06 | (34.98) | (46.18) |
Columns are period end dates